Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion type Assertion NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_head.
- NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion description "[Thus, the current study examined the feasibility of designing and utilizing a peptide, termed 599, consisting of a synthetic influenza virus-derived endosome-disruptive fusogenic peptide sequence and a stretch of cationic cell-penetrating nona(D-arginine) residues, to deliver siRNAs into oral cancer cells and induce silencing of the therapeutic target, CIP2A, an oncoprotein overexpressed in various human malignancies including oral cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_provenance.
- NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion evidence source_evidence_literature NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_provenance.
- NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion SIO_000772 24019920 NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_provenance.
- NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion wasDerivedFrom befree-20150227 NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_provenance.
- NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_assertion wasGeneratedBy ECO_0000203 NP932611.RArne3rWne9ovgxxgEIfOA6jv2ChbvbVHaEVgSDTM9rcw130_provenance.